Medications	Observed frequency of administration	Patients (N)	Number of Patients on LAI antipsychotics at study sites			Average Dose (mg)	Minimum Dose (mg)	Maximum Dose (mg)	Average prescribed doze per study site (mg/week)			Overall Average prescribed dose (mg/week)	Maximum recommended doze (mg/week) (CPS, 2018) [34]
Medications	Observed frequency of administration	Patients (N)	RPC	DC	SH	Average Dose (mg)	Minimum Dose (mg)	Maximum Dose (mg)	RPC	DC	SH	Overall Average prescribed dose (mg/week)	Maximum recommended doze (mg/week) (CPS, 2018) [34]
Flupentixol decanoate	10 Days	1	1	0	0	100.00	100.00	100.00	70	-	19.35	44.7 ± 35.8	40
	1 month	1	0	0	1	20.00	20.00	20.00
	2 weeks	13	0	0	13	43.08	20.00	100.00
	3 weeks	2	0	0	2	60.00	60.00	60.00
	4 weeks	4	0	0	4	43.75	20.00	75.00
	Total	21	1	0	20
Fluphenazine decanoate	2 weeks	7	2	1	4	77.14	25.00	175.00	30.47	50	18.62	33.0 ± 15.8	50
	3 weeks	2	0	0	2	62.50	25.00	100.00
	4 weeks	3	2	0	1	17.00	1.00	25.00
	Total	12	4	1	7
Haloperidol decanoate	2 weeks	4	1	1	2	162.50	100.00	250.00	41.6	50	86.1	59.2 ± 23.6	100
	3 weeks	2	1	0	1	100.00	100.00	100.00
	Total	6	2	1	3	141.67	100.00	250.00
Pipotiazine palmitate	2 weeks	2	0	0	2	62.50	50.00	75.00	-	19.7	31.25	25.5 ± 8.2	83.3
	3 weeks	1	0	1	0	100.00	100.00	100.00
	4 weeks	1	0	1	0	25.00	25.00	25.00
	Total	4	2	0	2
Risperidone consta	1 month	1	0	0	1	37.50	37.50	37.50	15.62	21.8	17.6	18.3 ± 3.2	25
	2 weeks	22	6	2	14	35.89	12.50	50.00
	3 weeks	1	0	0	1	37.50	37.50	37.50
	Total	24	6	2	16
Zuclopenthixol decanoate	10 Days	1	0	1	0	350.00	350.00	350.00	97.7	165	116.9	126.5 ± 34.7	600
	1 month	1	0	0	1	200.00	200.00	200.00
	1 weeks	1	1	0	0	100.00	100.00	100.00
	2 weeks	42	10	2	30	245.83	75.00	400.00
	3 weeks	4	0	0	4	187.50	150.00	200.00
	4 weeks	4	0	0	4	325.00	200.00	400.00
	Total	53	11	3	39
Grand Total		120	24	9	87